The Lancet has announced the formation of a Commission on colorectal cancer, aiming to tackle a disease that accounts for approximately 10% of all cancer incidence globally. The initiative comes as nearly 1 million deaths were recorded from colorectal cancer between 2020 and 2022.
This burden is expected to grow dramatically, with projections indicating over 3.2 million new cases and 1.6 million deaths annually by 2040. The epidemiological landscape is shifting, with diagnoses occurring at younger ages and at more advanced stages.
The commission will focus on the evolving patterns of the disease, including a higher proportion of left-sided tumors and a rapid shift toward earlier onset. These trends underscore the urgent need for updated screening and prevention strategies.
As the global health community grapples with rising cancer rates, the commission's work could reshape policy and clinical practice. Its findings may influence screening guidelines and resource allocation in both developed and developing nations.
Some experts caution that without substantial investment in early detection infrastructure, particularly in low-income regions, these projections may underestimate the true future burden.